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The rat pheochromocytoma PC12 cell line is a widely used system to study
neuronal differentiation for which sustained activation of the extracellular signaling
related kinase (ERK) pathway is required. Here, we investigate the function of MKSTYX [MAPK (mitogen-activated protein kinase) phosphoserine/threonine/tyrosinebinding protein] in neuronal differentiation. MK-STYX is a member of the MAPK
phosphatase (MKP) family, which is generally responsible for dephosphorylating
the ERKs. However, MK-STYX lacks catalytic activity due to the absence of the
nucleophilic cysteine in the active site signature motif HC(X5)R that is essential for
phosphatase activity. Despite being catalytically inactive, MK-STYX has been
shown to play a role in important cellular pathways, including stress responses.
Here we show that PC12 cells endogenously express MK-STYX. In addition, MKSTYX, but not its catalytically active mutant, induced neurite-like outgrowths in
PC12 cells. Furthermore, MK-STYX dramatically increased the number of cells with
neurite extensions in response to nerve growth factor (NGF), whereas the
catalytically active mutant did not. MK-STYX continued to induce neurites in the
presence of a MEK (MAP kinase kinase) inhibitor suggesting that MK-STYX does
not act through the Ras-ERK/MAPK pathway but is involved in another pathway
whose inactivation leads to neuronal differentiation. RhoA activity assays indicated
that MK-STYX induced extensions through the Rho signaling pathway. MK-STYX
decreased RhoA activation, whereas RhoA activation increased when MK-STYX
was down-regulated. Furthermore, MK-STYX affected downstream players of
RhoA such as the actin binding protein cofilin. The presence of MK-STYX
decreased the phosphorylation of cofilin in non NGF stimulated cells, but increased
its phosphorylation in NGF stimulated cells, whereas knocking down MK-STYX
caused an opposite effect. Taken together our data suggest that MK-STYX may be
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a regulator of RhoA signaling, and implicate this pseudophosphatase as a regulator
of neuronal differentiation.

Introduction
PC12 cells serve as a model for neuronal cell differentiation because they
differentiate in response to neurotrophins [1–4]. Moreover, they respond to nerve
growth factor (NGF) and epidermal growth factor (EGF) differently. While both
growth factors require Ras activation to stimulate the ERK/MAPK (extracellular
regulated kinase/mitogen-activated protein kinase) pathway [5, 6], NGF induces a
sympathetic neuron-like phenotype, while EGF promotes proliferation [7]. The
differential response in PC12 cells is widely accepted to be due to differences in the
duration of MAPK activation. NGF causes sustained activation of MAPK,
implying sustained MAPK phosphorylation [2, 8–10], whereas EGF causes
transient activation, implying rapid dephosphorylation [11-13]. Numerous
studies support a model in which sustained MAPK activation is required for
neuronal differentiation [21, 25, 29]. Furthermore, sustained MAPK activation is
well characterized as an inducer of neuronal differentiation of PC12 cells [10, 14].
However, the mechanisms of PC12 neuronal differentiation are incompletely
understood. Other signaling pathways, such as the Rho/ROCK (RhoA kinase)
pathway, have been implicated in PC12 differentiation as well [2, 15–17].
The duration and extent of MAPK activation depends on the activity of both
kinases and phosphatases that regulate MAPK signaling [18–20]. Most MAPKs are
substrates for members of the dual specificity protein tyrosine phosphatases that
hydrolyze phospho-serine, -threonine, and -tyrosine residues on MAPK, and thus
are termed MAPK phosphatases (MKPs) [21]. The protein tyrosine phosphatase
SHP-2 is required for Ras and MAPK activation and neuronal outgrowth [22, 23].
Furthermore, the dephosphorylation of ERK1/2 MAPK by MKPs plays an
important role in ERK signaling in both time and space [24]. Three MKPs, MKP1, MKP-2, and MKP-3, have been implicated in neuronal differentiation and are
expressed in a wide variety of tissues and cell types, including PC12 cells.
Intriguingly, both EGF and NGF elicit a rapid increase in MKP-1 and MKP2 mRNAs levels in PC12 cells [25], whereas only NGF induces a rapid increase in
MKP-3 mRNA levels [26]. Although all three MKPs inhibit MAPK activation,
MKP-3 has been studied more extensively in neuronal cells [25–27]. MKP-3 is
significantly up-regulated and sustained for five days in PC12 cells stimulated by
NGF [26], and is a known regulator of the duration of MAPK activation [28].
However, this does not address whether the rapid production of MKP leads to the
transient MAPK response to EGF.
The prototypical catalytically inactive pseudophosphatase, STYX (serine
threonine tyrosine interacting protein), has a glycine residue at the position
expected for the active-site cysteine residue [29]. Initially it was proposed that

PLOS ONE | DOI:10.1371/journal.pone.0114535 December 5, 2014

2 / 20

MK-STYX Induces Neurite-Like Outgrowths

STYX represented a new class of pSer/pThr/pTyr-binding proteins that function
as dominant negative antagonists of endogenous protein phosphatases [30]. STYX
associates with the spermatid phosphoprotein CRHSP-24 (calcium-responsive
heat-stable protein with a molecular mass of 24k Da), which is a unique RNA
binding protein. STYX knockout mice are defective for sperm production,
revealing an essential function in spermatogenesis [31]. During neuronal
differentiation, STYX competes with MKP-2 for binding to ERK1/2 MAPKs [32].
Moreover, it reduces activation of ERK1/2 MAPK and, thereby, blocks PC12
differentiation [32]. Considering that STYX is not a member of the MKP family,
its role in the ERK signaling pathway was unexpected. In fact the interaction
between STYX and ERK signaling was pursued only because of computational
modeling based on the ERK/MAPK activation by MEK (MAP kinase kinase) [32].
Thus, we asked what would be the role of a pseudophosphatase that is a member
of the MKP family in neuronal differentiation?
The pseudophosphatase MK-STYX is a product of the DUSP24 gene, which has
homology to the MKP-3 gene [33]. However, MK-STYX is a unique member of
the MKP family [34]. The active site signature motif HC(X5)R is essential for
phosphatase activity, but MK-STYX has the sequence IFSTQGISRS, which
renders it catalytically inactive [30, 33, 34]. Mutations made in MK-STYX that
restore this signature motif generate an active phosphatase (MK-STYXactive) [34].
Despite being catalytically inactive, MK-STYX plays a role in a number of
important cellular pathways [34–36], including inhibition of apoptosis and stress
granule formation [34, 35, 37]. The functionality of MK-STYX is underexplored
and still remains elusive; however, as with active MKP homologs, determining its
interaction partners has helped elucidate some of the functions of MK-STYX
[34, 38]. In earlier studies concerning the cellular function of MK-STYX, we
discovered that it binds G3BP-1 (Ras-GTPase activating protein SH3 domain
binding protein-1), which regulates both the Ras signaling pathway and stress
granule assembly [1]. We determined that MK-STYX inhibits stress granule
formation [34]. Dephosphorylation of G3BP-1 at Ser149 is critical for stress
granule formation [39]; however, MK-STYX’s interaction with G3BP-1 and its
effect on the stress granule pathway is independent of the phosphorylation status
of Ser 149 [37].
Given the apparent role of STYX in MAPK activation, this study focused on the
role of MK-STYX in PC12 cell differentiation. Opposite to the effects of STYX,
MK-STYX, but not the catalytically active mutant, induced neurite-like
outgrowths. MK-STYX dramatically increased the number of cells with neurite
extensions in response to NGF, whereas MK-STYXactive decreased the number of
cells with extensions. MK-STYX continued to induce neurites in the presence of a
MEK inhibitor. These data suggest that MK-STYX does not function through the
ERK/MAPK signaling pathway like STYX does, confirming previous findings in
our lab, and a report that MK-STYX has no effect on ERK activation [35]. Rather,
we show that MK-STYX induced extensions through the Rho signaling pathway.
MK-STYX overexpression decreased RhoA activation, and RhoA activation
increased when MK-STYX was down-regulated, Moreover, MK-STYX effected
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downstream targets such as cofilin, which has a major role in actin filament
networks [40]. MK-STYX decreased cofilin phosophorylation in non-stimulated
cells, but increased cofilin phosphorylation 24 hours after NGF stimulation.
Taken together, our data provide evidence that MK-STYX acts as a regulator in
the Rho signaling pathway and neuronal differentiation.

Materials and Methods
Cell Culture and Transient Transfection
PC12 (rat pheochromocytoma) cells (ATCC) were maintained at 37 ˚C, 5% CO2 in
Roswell Memorial Institute (RPMI) medium (Gibco, Invitrogen) supplemented
with 10% horse serum (Invitrogen) and 5% fetal bovine serum (FBS) (Invitrogen)
or high glucose Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Invitrogen)
supplemented with 10% FBS. Using Lipofectamine 2000 (Invitrogen), cells were
transfected with expression plasmids pMT2, pMT2-FLAG-MK-STYX-FLAG, or
pMT2-FLAG-MK-STYXactive-FLAG and pEGFP. Cells were either not stimulated
or stimulated with nerve growth factor (NGF), or treated with a MEK inhibitor
for the subsequent experiments, and analyzed with fluorescence microscopy.

Live Cell Imaging and Scoring Cells
Cells were seeded at 1.56105 cells in a 60 mm dish (Fisher) and transfected 16 or
24 hr post seeding. Live cell imaging of EGFP-expressing cells was conducted with
phase contrast and fluorescence microscopy using a Nikon ECLIPSE Ti inverted
fluorescence microscope. Cells were observed over a five day period. Cells were
scored either day 3 or 5 post-treatment for ‘‘neurites,’’ defined as neurite-like
outgrowths §20 mm in length. Cells were scored at least by day 3, when the
outgrowths were clearly visible. Neurite outgrowth length was measured with
NIS-Elements Basic Research software (version 3.10, Nikon). At least three
replicate transfections were performed and at least 100 cells were scored per
replicate. Samples were scored blind with regard to treatment and were scored
independently by at least two different individuals. Cells were scored into two
categories: no neurites and neurites, except for the initial experiments where cells
were categorized as ,20, 20–40, 40–60, 60–80, 80–100, 100+ mm. Since this
experiment showed neurite extensions longer than 20 mm to be characteristic of
differentiation, subsequent studies focused on cells producing extensions
.20 mm.

NGF Stimulation
Twenty-four hr post-transfection, PC12 cells were serum-starved in RPMI
supplemented with 1% horse serum or DMEM with no serum for 8–12 hr and
then stimulated with 100 ng/ml of NGF (Prospec). For time-dependent NGF
stimulation, cells were lysed at 0 min, 1 min, 3 min, 5 min, 12 min, 30 min,
24 hr, and 48 hr.
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Immunoblotting
PC12 cells were transfected with pMT2-FLAG-MK-STYX-FLAG, or MK-STYX
specific shRNA expression plasmids, lysed, and analyzed by western blotting. Cells
were harvested in lysis buffer (50 mM HEPES, pH 7.2, 150 mM NaCl, 10%
glycerol, 10 mM NaF, 1% Nonidet P-40 alternative [Calbiochem], and protease
inhibitor cocktail tablets [Roche]). Lysates were centrifuged at 14,0006g for
10 min, and the supernatant protein concentration was determined by NanoDrop
quantification. Lysates were resolved by 10% SDS-PAGE or 12% SDS-PAGE
(cofilin experiments) and transferred to PVDF membrane by iBlot (Invitrogen)
for immunoblot analysis with anti-FLAG (Sigma), anti-STYXL1 (antibody against
MK-STYX, Sigma), phospho-cofilin (Cell Signaling), cofilin (Cell Signaling) or
anti-ß tubulin (Pierce) antibodies, followed by chemiluminescent detection.
When warranted, blots were stripped (200 mM glycine, 3.5 mM SDS, 1% Tween
20), and re-probed.

MK-STYX Knockdown
Control or MK-STYX-specific shRNA expression plasmids (Qiagen) were
transfected into PC12 cells for 24 hr. RNA was isolated from the cells with
RNAzol (MRC). cDNA synthesis was performed with RT2 First Strand Kit
(Qiagen), and real time PCR was performed with RT2 SYBER Green ROX qPCR
Mastermix (Qiagen) and RT2 qPCR Primer Assay [primers specific for STYXL1
(MK-STYX)] (Qiagen). Gene expression was tracked in real time using the
Applied Biosystems StepOne Real-Time PCR-System. Triplicates were performed
to determine the optimal amount of MK-STYX shRNA. Knockdown was also
further analyzed by immunoblotting. Twenty-four hr post-transfection cells were
stimulated with 100 ng/ml NGF and analyzed for neurite outgrowth.

MEK Inhibition
The MEK inhibitor PD98059 (Cell Signaling) was reconstituted in DMSO
according to the manufacturer’s protocol. Cells were seeded at 1.56105 in a
60 mm dish and transfected 16 or 24 hr post seeding. 24 hr post-transfection cells
were treated with 50 mM PD98059 for one hour and then stimulated with 100 ng/
ml NGF for 3 days (media was replaced every 24 hr with treatment media), and
live cell images were taken. Experiments were performed four times.

Rho Activity Assays
Cells were stimulated at various time points with NGF, harvested with lysis buffer,
immediately snap-frozen with liquid nitrogen, and stored at 280 ˚C until Rho
activity assays were performed. The Cytoskeleton Inc. manufacturer’s protocol for
RhoA G-LISA or RhoA ELISA was followed. RhoA G-LISA and ELISA were also
performed for knockdown experiments. RhoA ELISA was used to normalize the
RhoA G-LISA assay. Three replicate experiments were performed per assay.
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Results
MK-STYX induces neurite outgrowth formation in PC12 cells
Since we previously identified G3BP-1 as an interacting binding partner of MKSTYX [34], and another pseudophosphatase, STYX, inhibits PC12 cell
differentiation, we sought to determine whether MK-STYX has an effect on
neuronal signaling by using PC12 cells as the model. To determine whether MKSTYX induces or inhibits neurite formation, PC12 cells were transfected with
pEGFP and pMT2, MK-STYX, or MK-STYXactive and observed for neurite
outgrowth. By day 5, the results were striking; cells transfected with MK-STYX
and pEGFP developed neurites, whereas those transfected with MK-STYXactive,
pMT2 or pEGFP did not (Figure 1A). Significantly more of the cells transfected
with MK-STYX and pEGFP (,55%) had neurites, as compared to control cells
expressing the empty pMT2 and pEGFP vectors (,22%) or pEGFP alone (,25%)
(ANOVA: F2,8576.10, p,0.0001) (Figure 1B). These outgrowths were a result of
expressing MK-STYX alone.

MK-STYX enhances the effects of NGF
To determine the PC12 outgrowth lengths, cells were imaged and the extensions
were measured from the body to the end as depicted in Figure 2A, where the
neurite-like outgrowth measured was 172.5 mm. As the standard in subsequent
experiments, an outgrowth §20 mm was considered to be a neurite-like
outgrowth. To analyze MK-STYX’s effects on normal cellular signaling in
response to growth factors further, we stimulated cells co-expressing pEGFP and
pMT2 or MK-STYX with NGF. NGF caused neurite extension in all cells, but MKSTYX shifted the distribution to much longer outgrowths (Figure 2B).
To examine the effect of MK-STYX on NGF-stimulated PC12 cells further, we
also analyzed the active mutant, which is capable of dephosphorylation [34, 37].
Unlike MK-STYX, MK-STYXactive did not induce neurites (Figure 2C), but
reduced them significantly (37%) (ANOVA (F2,8543.81, p,0.001) in NGF
stimulated cells (Figure 2D) as compared to wild-type MK-STYX (,79%), or the
control (50%) (Figure 2E). Neurites in cells transfected with MK-STYX and
stimulated with NGF branched more (Figure 2D) than either the control or nonstimulated cells over-expressing MK-STYX. The neurite-like extensions of these
cells separated further (depicted by white arrows). When primary neurites
(extension connected to the cell body) divide further, this process is referred to as
‘‘branching out’’ [41].

MK-STYX is required for NGF stimulated PC12 neurites
First, to determine whether MK-STYX is endogenously expressed in PC12 cells,
cell extracts were subject to immunoblot analysis. A single band on blots probed
with anti-STYXL1 confirmed that MK-STYX is endogenously expressed
(Figure 3A, lane 1). In PC12 cells over-expressing FLAG-tagged MK-STYX, the
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Figure 1. Pseudophosphatase MK-STYX induces neurite extensions in PC12 cells. (A) Representative
examples are presented to illustrate neurite outgrowths of PC12 cells over-expressing MK-STYX and GFP,
MK-STYXactive, or pMT2 control plasmid and GFP. Cells were incubated 5 days. (B) Cells transfected with
pEGFP, pMT2, or pMT2-FLAG-MK-STYX-FLAG plasmids were scored for neurite extensions >20 mm with a
phase objective. Three replicate experiments were performed (n5100 cells per experiment); the results are ¡
SEM. Statistical analysis was performed using ANOVA (F2,8576.10, ***p,0.0001).
doi:10.1371/journal.pone.0114535.g001

exogenous proteins were detected by both anti- STYXL1 and anti-FLAG (
Figure 3A, lane 2).
Next, to determine the effects of MK-STYX specific expression plasmids, cells
were transfected with various clones. Cells transfected with MK-STYX shRNA
Clone A (MK-STYX shRNA-A) or Clone C (MK-STYX shRNA-C) showed the
greatest knockdown of MK-STYX mRNA levels, at 42% and 32%, respectively (
Figure 3B), as well as knockdown of protein levels (Figure 3C). To determine the
importance of MK-STYX in neurite outgrowths in PC12 cells, cells were
transfected with shRNAs against MK-STYX, stimulated with NGF, and observed
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Figure 2. MK-STYX shifts the distribution of neurite outgrowth lengths. (A) The length of a neurite-like outgrowth of PC12 cells over-expressing GFP
and MK-STYX was measured to demonstrate how cells were scored for outgrowths §20 mm. (B) PC12 cells over-expressing GFP and MK-STYX or pMT2
control plasmid for 24 hr were stimulated with 100 ng/ml NGF. Twenty-four hr post-stimulation cells were scored (n5200) for outgrowth length. Cells were (C)
not stimulated or (D) stimulated with 100 ng/ml of NGF. White arrows indicate ‘‘branching out’’ of primary neurites. (E) Cells were scored for neurite
extensions §20 mm, and statistical analysis was performed using ANOVA (F2,8543.81, ***p,0.001).
doi:10.1371/journal.pone.0114535.g002

for neurite outgrowths. Eighty two percent of cells expressing the scrambled
shRNA negative control had neurite outgrowths. In contrast, only 24% of cells
expressing MK-STYX shRNA-A and 46% of cells expressing MK-STYX shRNA-C
formed neurites (Figure 3D), providing evidence that MK-STYX is important for
neurite outgrowth in PC12 cells. Statistical analysis was performed using ANOVA
(F2,85357.85, p,0.0001). Furthermore, there was a dramatic difference in the
phenotype in cells where MK-STYX had been down-regulated (Figure 3E). Cells
expressing MK-STYX shRNA-A or MK-STYX shRNA-C appeared more rounded,
whereas those expressing the scrambled control formed neurites similar in
morphology to non-transfected cells (Figure 3E) that were used as a positive
control.

MK-STYX induces neurites in the presence of a MEK inhibitor
To determine whether MK-STYX induces neurites in PC12 cells through the ERK/
MAPK pathway, MEK, which is necessary for ERK/MAPK activation [42], was
blocked by PD98059, a MEK-specific inhibitor. Neurites formed in cells
coexpressing pMT2 and pEGFP, or MK-STYX and pEGFP (Figure 4A and C), but
in the presence of the inhibitor the formation of neurites decreased by 50% (
Figure 4B and C) in the control cells expressing pMT2 and pEGFP stimulated
with NGF (t-test; p,0.01). In contrast, MK-STYX maintained its ability to induce
neurites in the presence of PD8059 (Figure 4B and C). The fact that MK-STYX
induced neurites in the presence of MEK (t-test; p,0.01), suggests that MK-STYX
acts further downstream in the ERK/MAPK pathway or through a different
pathway to induce neuronal differentiation in PC12 cells. Furthermore, MK-STYX
did not affect Ras activity (data not shown), and immunoblot analysis
demonstrated that ERK activation was not affected by MK-STYX (data not
shown), consistent with our previous data from Cos-1 cells (unpublished), and
reported findings in HeLa cells [35].

MK-STYX decreases RhoA activation
We performed Rho activation assays to test further whether MK-STYX functions
independently of the ERK/MAPK pathway. Inactivation of Rho has been shown to
be required for neurite induction in PC12 cells [16]. Strikingly, MK-STYX
prevented RhoA activation (Figure 5A), and levels of active RhoA remained low
and consistent throughout the duration of the experiment. In contrast, there was a
significant increase in the percentage of active RhoA in control cells within
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Figure 3. Knockdown of MK-STYX prevents NGF stimulated PC12 neurite extensions. (A) PC12 cells were transfected with pMT2-FLAG-MK-STYXFLAG. Transfected and non-transfected PC12 cells were lysed and immunoblots performed. Blots were probed with anti-STYXL, to detect endogenous MKSTYX, and anti-FLAG to detect over-expressed MK-STYX. (B) PC12 cells were transfected with shRNA against MK-STYX. Quantitative RT-PCR analysis of
MK-STYX mRNA levels after knockdown with three specific shRNAs targeting unique regions of MK-STYX. MK-STYX shRNA-A provided the best
knockdown of endogenous MK-STYX at 42%, compared to Clone B (MK-STYX-shRNA-B) (,15%) or Clone C (MK-STYX-shRNA-C) (,32%). (C) PC12
cells transfected with control, MK-STYX shRNA-A, or MK-STYX shRNA-C were lysed and immunoblotted. Anti-STYXL1 antibody showed that endogenous
MK-STYX was down-regulated by both MK-STYX shRNA-A and MK-STYX shRNA-C relative to the scrambled negative control. The blot was stripped and
probed with anti-ß tubulin as a loading control. Replicate experiments were performed. (D) Cells expressing negative control, MK-STYX shRNA-A, or MKSTYX shRNA-C were scored for neurite extensions >20 mm. Three replicate experiments were performed (n5100 cells per experiment); error bars indicate
¡ SEM. Statistical analysis was performed using ANOVA (F2,85357.85, ***p,0.0001). (E) Representative examples of PC12 cells over-expressing
shRNAs against MK-STYX (MK-STYX shRNA-A, MK-STYX shRNA-C, or scrambled negative control. The shRNA expression plasmids co-express GFP,
which allows visualization of successful transfection. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and 72 hr post-stimulation images
were taken with phase contrast or fluorescence microscopy. Untransfected cells treated with NGF served as a positive control for neurite outgrowth.
doi:10.1371/journal.pone.0114535.g003

30 minutes (p,0.05); activation was sustained for 24 hr and then declined back
to baseline levels after 48 hr.
RhoA has multiple roles in neuronal differentiation of PC12 cells, and its
inactivation is required during the initial stages of differentiation [16]. This
commitment of PC12 cells usually occurs within 24–48 hr, after RhoA activity has
declined to minimal levels [43, 44].
We performed knockdown studies to determine the effect of down-regulation
of MK-STYX on Rho activation. Because cells expressing MK-STYX shRNA-A
showed the greatest decrease in MK-STYX levels (see Figure 3B and C), this
shRNA construct was used in the RhoA activation experiment. To understand the
dynamics of MK-STYX further, the active mutant was also included in these
studies. Cells over-expressing MK-STYXactive stimulated with NGF for 24 hr had a
dramatic increase in RhoA activation compared to cells over-expressing MKSTYX stimulated with NGF for 24 hr or scrambled control (Figure 5B). However,
when endogenous MK-STYX was knocked down by MK-STYX shRNA-A, RhoA
activation dramatically increased compared to cells over-expressing MK-STYX
stimulated with NGF for 24 hr or the scrambled control (Figure 5B) [ANOVA
(F3,955.066, p,0.01)]. These findings suggest a role for MK-STYX in regulating
Rho activity.

MK-STYX affects RhoA downstream target cofilin
Since we showed that MK-STYX inactivates RhoA, the question arose whether
MK-STYX has an effect on downstream targets of RhoA. To address this question
we analyzed phosphorylation of cofilin, an actin binding protein that is regulated
by RhoA. Cells were transfected with MK-STYX, scrambled control, or MK-STYX
shRNA-A and either stimulated with NGF for 24 hr or not. Cofilin
phosphorylation decreased in cells over-expressing MK-STYX or scrambled
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Figure 4. MK-STYX induces neurites in the presence of MEK inhibitor (PD98059). Representative
examples of PC12 cells over-expressing pMT2 and GFP, or MK-STYX and GFP, that were stimulated with
100 ng/ml NGF and (A) treated with, or (B) not treated with 50 mM PD98059. (C) Cells were scored for neurite
extensions §20 mm. Statistical analysis was performed with t-tests for control group (pMT2 and pEGFP;
**p,0.01) and experimental group (MK-STYX and pEGFP; **p,0.01).
doi:10.1371/journal.pone.0114535.g004

control in unstimulated cells, compared with the levels of phospho-cofilin present
shRNA-A-expressing cells. However, 24 hr post NGF stimulation, cofilin
phosphorylation increased in cells over-expressing MK-STYX. Taken together,
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Figure 5. MK-STYX decreases RhoA activation. (A) PC12 cells were transfected with pMT2 or pMT2FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the
indicated time points. Activation of RhoA was quantified by RhoA G-LISA small G-protein assay. Total RhoA
was normalized by RhoA ELISA. Three replicate experiments were performed. Error bars indicate ¡ SEM.
Statistical analysis was performed using multiple t-tests, and there was a significant increase in the
percentage of active RhoA in pMT2-expressing control cells within 30 minutes (p,0.05) (B) PC12 cells were
transfected with pMT2-FLAG-MK-STYX-FLAG, MK-STYX shRNA-A, or scrambled shRNA. 24 hr posttransfection cell were stimulated with 100 ng/ml NGF, lysed, and RhoA activation was quantified by RhoA G-
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LISA small G-protein assay. Total RhoA was normalized by RhoA ELISA. Three replicate experiments were
performed. Error bars indicate ¡ SEM. Statistical analysis was performed using ANOVA (F3.955.066,
**p,0.01; *p,0.05). (C) PC12 cells transfected with MK-STYX, scrambled shRNA, or MK-STYX shRNA-A.
24 hr post-transfection cells were stimulated with NGF or not, and were lysed 24 hr thereafter and
immunoblotted. Anti-phospho-cofilin antibody showed that MK-STYX decreased cofilin phosphorylation in
non-stimulated cells relative to the MK-STYX shRNA-A. However, MK-STYX increased cofilin
phosphorylation in cells stimulated with NGF relative to the MK-STYX shRNA-A. These blots were stripped
and probed for cofilin as a loading control. Anti-STYXL1 antibody showed over-expressed MK-STYX relative
to the scrambled control, and that endogenous MK-STYX was down-regulated by MK-STYX shRNA-A relative
to the scrambled negative control. The blot was stripped and probed with anti-FLAG to detect over-expressed
MK-STYX, and probed for anti-ß tubulin as a loading control. Three replicate experiments were performed.
doi:10.1371/journal.pone.0114535.g005

these data suggest that MK-STYX may play an important role in cofilin activation
and inactivation, and in the actin filament network.

Discussion
There is an abundant population of human pseudoenzymes within the kinase and
phosphatase families that may play key roles in signaling cascades [45, 46]. Yet,
nearly two decades after the discovery of the prototypical pseudophosphatase,
STYX [29, 30], little is known about the functions or molecular mechanisms of the
majority of the pseudophosphatases. The C. elegans EGG pseudophosphatases
serve as the best mechanistic examples; EGG4 and EGG5 bind and regulate
signaling through the dual-specificity tyrosine-phosphorylated and -regulated
kinase family mini brain kinase 2 [45, 47]. Previous studies have shown that MKSTYX is a master regulator of apoptotic potential of the mitochondria [35].
Knockdown of MK-STYX blocks release of cytochrome c, and prevents cells from
undergoing apoptosis [35]. Recently, a model was provided for the molecular
mechanism by which MK-STYX controls apoptosis, suggesting that MK-STYX
negatively regulates PTPM1 (PTP localized to the mitochondrion 1). MK-STYX
interacts with PTPM1 and inhibits its catalytic activity, regulating cell viability
[38]. Such interactions between a pseudophosphatase and an active phosphatase
are also seen among the myotubularin phosphatases [38]. However, binding of the
myotubularin pseudophosphatase to its active homolog enhances phosphatase
activity [48]. Previously, we reported that MK-STYX has a role in the stress
response pathway by inhibiting stress granule formation [34, 37]. In this study, we
report that it is important for neurite outgrowth in PC12 cells and decreases RhoA
activation.
It has been suggested that pseudophosphatases serve a ‘‘dominant-negative’’
function by physically masking the phosphorylated residues, thereby blocking
access of phosphatases, and protecting substrates from dephosphorylation
[45, 49]. Thus, it seemed plausible that a pseudophosphatase might have a role in
sustaining the MAPK activation required for PC12 neuronal differentiation.
Findings with STYX have shown that this pseudophosphatase competes with
MKP-2 to bind ERK1/2 MAPK [32]; however, STYX’s interaction with ERK1/2
MAPK is much more dynamic than merely serving as a blocker. STYX acts as a
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nuclear anchor for ERK1/2 MAPK, thereby regulating its activation [32].
Furthermore, over-expression of STYX prevents PC12 differentiation [32].
In contrast, we show that over-expressing MK-STYX induces neurite-like
outgrowths, a hallmark of PC12 differentiation. In addition to inducing
outgrowths, when cells expressing MK-STYX were stimulated with NGF, longer
neurites formed and more branching occurred, suggesting these cells are
becoming neuronal. By analogy with the STYX results, we thought that MK-STYX
might exert its effects on PC12 differentiation through the Ras-ERK/MAPK
pathway. However, our studies with the MEK inhibitor provide evidence that
MK-STYX does not function through Ras-ERK/MAPK, but further downstream
or by another pathway. Furthermore, we have observed that MK-STYX does not
have an effect on Ras activation in the presence or absence of NGF (unpublished
observations). Other studies have reported that NGF-dependent survival of PC12
cells may be mediated by other pathways such as the phosphatidylinositol-3kinase pathway [50, 51]. Here, we show that MK-STYX is involved in the RhoA
signaling pathway, which also has been implicated in PC12 neuronal
differentiation [16]. Further support for a role of MK-STYX in the RhoA signaling
pathway comes from the branching out pattern seen in the presence of MK-STYX
and NGF. This branching out pattern may represent the formation of dendrites
[52], which are important for neuronal communication [41, 53, 54]. Furthermore,
these extensions appear to overlap, suggesting that MK-STYX may have a role in
branching [41], which is regulated by the Rho GTPases.
In addition, MK-STYX affected the RhoA downstream target cofilin, Cofilin has
a dual role in the actin filament network, to depolymerize and/or sever actin
[55, 56]. When phosphorylated, cofilin is inactive, resulting in filament stability,
whereas dephosphorylation of cofilin leads to depolymerization [56–58] Thus,
cofilin is a modulator of the actin cytoskeleton architecture, and plays a pivotal
role in the rearrangement of the cytoskeleton that is required for neuronal
differentiation. We demonstrate that MK-STYX decreased cofilin phosphorylation
in the absence of NGF, which is required for the induction of neurites [59].
However, MK-STYX increased cofilin phosphorylation 24 hr post- NGF
stimulation, similar to the commitment period of PC12 cells to become neuronal
and begin branching [43, 44]. This supports the effects of MK-STYX on RhoA
activation beyond the 24 hr NGF stimulation, providing more substantial
evidence that MK-STYX has a role in RhoA signaling.
The Rho family of small GTPases has been implicated in reorganization of the
actin cytoskeleton and subsequent morphological changes in various cell types
[60, 61]. Rho family members serve as molecular switches by cycling between an
inactive GDP-bound state and an active GTP-bound state. At least two members
within this family, RhoA and RhoE, have been reported to have important roles in
PC12 neurite extension [62, 63]. RhoE causes neurite outgrowths in PC12 cells by
inhibiting the RhoA/ROCK-1 (Rho kinase) signaling cascade [62], and RhoA
inactivation is essential for PC12 neurite outgrowth [63]. Our results have
revealed a new component in the RhoA signaling pathway. We demonstrate here
that MK-STYX decreases RhoA activation, while down-regulation of MK-STYX
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increases RhoA activation. Considering that G3BP-1, the first identified binding
partner of MK-STYX [34], has been implicated to have a role in Rho signaling
pathways [64, 65], MK-STYX may be an important regulator in this pathway.
Furthermore, G3BP-1 also interacts with other macromolecules such as tau
mRNA and has been implicated in differentiation of neuronal cells [52, 66].
Important future studies include determining whether the neurite-like outgrowths
induced by MK-STYX differentiate into neurons, further analyzing MK-STYX’s
effects on branching, its molecular mechanism in PC12 differentiation, and the
mechanism by which MK-STYX inhibits Rho activation. For example, MK-STYX
may interact with the low molecular weight protein tyrosine phosphatase (LMWPTP), p190GAP, or RhoA to inhibit its activity and induce neurite formation.
There are several unanswered questions. However, pseudophosphatases have been
shown to regulate phosphatase activity positively or negatively [38, 48].
Furthermore, MK-STYX could directly interact with RhoA, preventing its
association with the membrane and rendering it inactive.
Various kinases and phosphatases have been implicated in controlling neuronal
development and regeneration [67]. Moreover, it is becoming apparent that
pseudokinases and pseudophosphatases are integral elements of signal transduction, and thus may exert important roles in the pathology of various diseases [68].
Although STYX was the first pseudophosphatase implicated in having a role in
PC12 cell differentiation by regulating ERK1/2 activation, the present study
provides the first evidence that MK-STYX has an effect very different from that of
STYX in this process. Over-expression of MK-STYX resulted in PC12 cell
differentiation, and knocking down MK-STYX prevented neurite formation,
suggesting that the pseudophosphatase plays an important role in PC12 cell
differentiation. However, MK-STYK differs from STYX’s role as an ERK1/2
regulator, in that MK-STYX bypasses Ras-ERK/MAPK signaling or functions
through another pathway. The precise mechanism underlying the effects of MKSTYX remains to be defined; however, results from this study support a mode of
action of MK-STYX through the RhoA signaling pathway. Further characterization of the role of MK-STYX in neuronal cells may generate new insights into
neuronal development and potential approaches to therapy for neurodegenerative
diseases such as amyotrophic lateral sclerosis or Alzheimer’s.
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